Literature DB >> 3494668

Cyclophosphamide-induced eosinophilia in the rat: concomitant changes in T-cell subsets, B cells and large granular lymphocytes within lymphoid tissues.

A W Thomson, I H Mathie, H F Sewell.   

Abstract

Cyclophosphamide (Cy) treatment (150 mg/kg) of Sprague-Dawley rats 48 hr before immunization with a T-dependent antigen, ovalbumin (OVA), resulted in striking bone marrow, blood and tissue eosinophilia, maximal at 14 days and concurrent with profound lymphopenia. This phenomenon has been tentatively attributed to selective elimination by Cy of T-suppressor cells. In this study, T-cell subsets, B cells and monocytes/macrophages were enumerated following alkaline phosphatase-anti-alkaline phosphatase (APAAP) staining of mononuclear cells isolated from lymphoid tissues of rats exhibiting eosinophilia. In lymph nodes, a significant increase in the A3/25+:OX-8+ ratio compared with normal was maintained from Day 7 to Day 14; in the spleen, however, this effect was no longer apparent by Day 14, due to the emergence of a population of OX-8+, OX-19- large granular lymphocytes. A seven-fold rise in splenic B-cell numbers (OX-12+) between Day 7 and Day 14 coincided with the eosinophilia. These findings are consistent with the potentiated production of TH-cell derived soluble factors affecting eosinophil production and differentiation, including possibly a rat equivalent of eosinophil differentiation factor, which in the mouse has been reported to have B-cell growth factor activity linked with eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494668      PMCID: PMC1453252     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Immunoregulation by natural killer cells.

Authors:  L V Abruzzo; C A Mullen; D A Rowley
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

2.  Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity.

Authors:  R Neta; S B Salvin
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

3.  Splenic modifications induced by cyclophosphamide in C3H/He, nude, and "B" mice.

Authors:  J P Kolb; M F Poupon; G M Lespinats; D Sabolovic; F Loisillier
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

4.  Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.

Authors:  A D Hess; P J Tutschka; G W Santos
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

5.  The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues.

Authors:  A N Barclay
Journal:  Immunology       Date:  1981-04       Impact factor: 7.397

6.  Cyclophosphamide pretreatment induces eosinophilia to nonparasite antigens.

Authors:  M A Vadas
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

7.  Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.

Authors:  A W Thomson; D K Moon; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

Review 8.  Effect of cyclophosphamide on immunological control mechanisms.

Authors:  J L Turk; D Parker
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

9.  Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.

Authors:  R J North
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice.

Authors:  A Mitsuoka; S Morikawa; M Baba; T Harada
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more
  10 in total

1.  Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.

Authors:  A Horroccks; A D Ormerod; J I Duncan; A W Thomson
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Combination chemo-immunotherapy: kinetics of in vivo and in vitro generation of natural killer cells and lymphokine-activated killer cells in the rat.

Authors:  L S Stewart; H F Sewell; A W Thomson
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

3.  Increased production of Kurloff cells and accompanying lymphocyte subset changes in immunized guinea-pigs treated with cyclophosphamide and cyclosporin A.

Authors:  A W Thomson; C A McPhee; H F Sewell
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

4.  Cyclophosphamide affects the dynamics of granuloma formation in experimental visceral leishmaniasis.

Authors:  E B Corrêa; J M Cunha; M M Bunn-Moreno; E D Madeira
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

5.  Dried Ginger Extract Restores the T Helper Type 1/T Helper Type 2 Balance and Antibody Production in Cyclophosphamide-Induced Immunocompromised Mice after Flu Vaccination.

Authors:  Jihyun Kim; Hoyoung Lee; Sooseong You
Journal:  Nutrients       Date:  2022-05-09       Impact factor: 6.706

6.  Interleukin-5 is necessary for eosinophilia induced by cyclophosphamide in immunized mice.

Authors:  H H Mu; R Penny; W A Sewell
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

7.  Allergen-induced airway responses in rats pretreated with Sephadex.

Authors:  P Rossi; L Xu; N S Wang; J G Martin
Journal:  Agents Actions       Date:  1993-11

8.  Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A.

Authors:  J Liversidge; H F Sewell; A W Thomson; J V Forrester
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

9.  Immunostimulatory Effects of Live Lactobacillus sakei K040706 on the CYP-Induced Immunosuppression Mouse Model.

Authors:  Seo-Yeon Kim; Ji-Sun Shin; Kyung-Sook Chung; Hee-Soo Han; Hwi-Ho Lee; Jeong-Hun Lee; Su-Yeon Kim; Yong Woo Ji; Yejin Ha; Jooyeon Kang; Young Kyoung Rhee; Kyung-Tae Lee
Journal:  Nutrients       Date:  2020-11-22       Impact factor: 5.717

10.  Strain-Specific Identification and In Vivo Immunomodulatory Activity of Heat-Killed Latilactobacillus sakei K040706.

Authors:  Kyung-Sook Chung; Jae Woong Choi; Ji-Sun Shin; Seo-Yeon Kim; Hee-Soo Han; Su-Yeon Kim; Kwang-Young Lee; Joo-Yeon Kang; Chang-Won Cho; Hee-Do Hong; Young Kyoung Rhee; Kyung-Tae Lee
Journal:  Foods       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.